Citation: G. Luporini et al., EFFICACY AND SAFETY OF LEVODROPROPIZINE AND DIHYDROCODEINE ON NONPRODUCTIVE COUGH IN PRIMARY AND METASTATIC LUNG-CANCER, The European respiratory journal, 12(1), 1998, pp. 97-101
Authors:
MARCHI E
VARGAS FS
TEIXEIRA LR
FAGUNDES DJ
SILVA LMMF
CARMO AO
LIGHT RW
Citation: E. Marchi et al., COMPARISON OF NITROGEN-MUSTARD, CYTARABINE AND DACARBAZINE AS PLEURALSCLEROSING AGENTS IN RABBITS, The European respiratory journal, 10(3), 1997, pp. 598-602
Authors:
COMINACINI L
GARBIN U
PASINI AF
PAULON T
DAVOLI A
CAMPAGNOLA M
MARCHI E
PASTORINO AM
GAVIRAGHI G
LOCASCIO V
Citation: L. Cominacini et al., LACIDIPINE INHIBITS THE ACTIVATION OF THE TRANSCRIPTION FACTOR NF-KAPPA-B AND THE EXPRESSION OF ADHESION MOLECULES INDUCED BY PROOXIDANT SIGNALS ON ENDOTHELIAL-CELLS, Journal of hypertension, 15(12), 1997, pp. 1633-1640
Citation: E. Marchi et al., QUASIPOLYHEDRAL SETS IN LINEAR SEMIINFINITE INEQUALITY SYSTEMS, Linear algebra and its applications, 255, 1997, pp. 157-169
Citation: L. Scapol et al., CAPILLARY ELECTROPHORESIS OF HEPARIN AND DERMATAN SULFATE UNSATURATEDDISACCHARIDES WITH TRIETHYLAMINE AND ACETONITRILE AS ELECTROLYTE ADDITIVES, Journal of chromatography, 735(1-2), 1996, pp. 367-374
Authors:
CAENAZZO C
GARBISA S
CEOL M
BAGGIO B
BORSATTI A
MARCHI E
GAMBARO G
Citation: C. Caenazzo et al., HEPARIN MODULATES PROLIFERATION AND PROTEOGLYCAN BIOSYNTHESIS IN MURINE MESANGIAL CELLS - MOLECULAR CLUES FOR ITS ACTIVITY IN NEPHROPATHY, Nephrology, dialysis, transplantation, 10(2), 1995, pp. 175-184
Authors:
GUFFANTI EE
SCARPAZZA P
COLOMBO D
CANALI S
RATTI D
SCARPAZZA G
MARCHI E
Citation: Ee. Guffanti et al., MOGUISTEINE, A NEW ANTITUSSIVE DRUG, HAS NO EFFECT ON STEADY-STATE THEOPHYLLINE PHARMACOKINETICS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, Advances in therapy, 12(3), 1995, pp. 185-197
Authors:
CASELLA N
ROSSI C
CALABRESE R
BELLELLI E
MARCHI E
MILANI MR
POGGI A
Citation: N. Casella et al., EFFECT OF HEPARINS WITH DIFFERENT DEGREE OF SULFATION ON B16BL6 MELANOMA LUNG COLONIES IN MICE, Thrombosis and haemostasis, 73(6), 1995, pp. 964-964
Authors:
STELLA M
ANDREASSI C
DIPIETRO N
MILANI MR
MARCHI E
POGGI A
Citation: M. Stella et al., MOLECULAR CHARGE-DEPENDENT EFFECTS OF HEPARIN DERIVATIVES ON THE IN-VITRO PROLIFERATION AND PROTEIN-KINASE-C (PKC) EXPRESSION IN RAT AORTICSMOOTH-MUSCLE CELLS (SMC), Thrombosis and haemostasis, 73(6), 1995, pp. 969-969
Authors:
BARBANTI M
CALANNI F
MARCHI E
SEMERARO N
COLUCCI M
Citation: M. Barbanti et al., DESMIN-370, A LOW-MOLECULAR-WEIGHT DERMATAN SULFATE, REDUCES THE WEIGHT OF PREFORMED THROMBI IN RATS MADE AFIBRINOGENEMIC BY ANCROD, Thrombosis and haemostasis, 73(2), 1995, pp. 287-290
Authors:
GAMBARO G
ENTURINI AP
CHIECO PO
BARBANTI M
MARCHI E
BORSATTI A
BAGGIO B
Citation: G. Gambaro et al., DIFFERENT HEPARIN DOSAGES ARE NEEDED TO AMELIORATE THE EVOLUTION OF DIFFERENT EXPERIMENTAL NEPHROPATHIES - DOES THIS MEAN DIFFERENT HEPARINTARGETS, Kidney international, 47(2), 1995, pp. 689-689
Authors:
FABBRI A
MOTTA E
FERRARI S
LONGHI C
MARCHI E
BACCI G
FIGUS E
MARCHESINI G
Citation: A. Fabbri et al., HIGH-DOSE METHOTREXATE TREATMENT AND LIVER-FUNCTION IN PATIENTS WITH OSTEOSARCOMA, Journal of internal medicine, 236(2), 1994, pp. 209-214
Authors:
RODA A
RODA E
MARCHI E
SIMONI P
CERRE C
PISTILLO A
POLIMENI C
Citation: A. Roda et al., IMPROVED INTESTINAL-ABSORPTION OF AN ENTERIC-COATED SODIUM URSODEOXYCHOLATE FORMULATION, Pharmaceutical research, 11(5), 1994, pp. 642-647
Citation: C. Cerletti et al., INTERACTION BETWEEN GLYCOSAMINOGLYCANS, PLATELETS, AND LEUKOCYTES, Seminars in thrombosis and hemostasis, 20(3), 1994, pp. 245-253
Authors:
SILVESTRO L
LANZAROTTI E
MARCHI E
GORI M
PESCADOR R
FERRO L
MILANI MR
DACOL R
COPPINI A
Citation: L. Silvestro et al., HUMAN PHARMACOKINETICS OF GLYCOSAMINOGLYCANS USING DEUTERIUM-LABELED AND UNLABELED SUBSTANCES - EVIDENCE FOR ORAL ABSORPTION, Seminars in thrombosis and hemostasis, 20(3), 1994, pp. 281-292
Authors:
MARCHI E
BARBANTI M
MILANI R
BRECCIA A
FINI A
GATTAVECCHIA E
Citation: E. Marchi et al., ORGAN GLYCOSAMINOGLYCAN DISTRIBUTION AFTER INTRAVENOUS AND ORAL-ADMINISTRATION IN RATS, Seminars in thrombosis and hemostasis, 20(3), 1994, pp. 297-300
Authors:
GAMBARO G
VENTURINI AP
NOONAN DM
FRIES W
RE G
GARBISA S
MILANESI C
PESARINI A
BORSATTI A
MARCHI E
BAGGIO B
Citation: G. Gambaro et al., TREATMENT WITH A GLYCOSAMINOGLYCAN FORMULATION AMELIORATES EXPERIMENTAL DIABETIC NEPHROPATHY, Kidney international, 46(3), 1994, pp. 797-806
Authors:
COMI GP
PRELLE A
BRESOLIN N
MOGGIO M
BARDONI A
GALLANTI A
VITA G
TOSCANO A
FERRO MT
BORDONI A
FORTUNATO F
CISCATO P
FELISARI G
TEDESCHI S
CASTELLI E
GARGHENTINO R
TURCONI A
FRASCHINI P
MARCHI E
NEGRETTO GG
ADOBBATI L
MEOLA G
TONIN P
PAPADIMITRIOU A
SCARLATO G
Citation: Gp. Comi et al., CLINICAL VARIABILITY IN BECKER MUSCULAR-DYSTROPHY - GENETIC, BIOCHEMICAL AND IMMUNOHISTOCHEMICAL CORRELATES, Brain, 117, 1994, pp. 1-14
Authors:
SCARPAZZA P
GUFFANTI EE
MARCHI E
CORSONELLO F
VOZZA A
SPEZIE I
Citation: P. Scarpazza et al., MULTICENTER EVALUATION OF PRAMIRACETAM FOR THE TREATMENT OF MEMORY IMPAIRMENT OF PROBABLE VASCULAR ORIGIN, Advances in therapy, 10(5), 1993, pp. 217-225
Authors:
CERIELLO A
QUATRARO A
ETTORRE M
MARCHI E
BARBANTI M
GIUGLIANO D
Citation: A. Ceriello et al., GLUCOSAMINOGLYCANS ADMINISTRATION DECREASES HIGH FIBRINOGEN PLASMA-LEVELS IN DIABETIC-PATIENTS, Diabetes, nutrition & metabolism, 6(4), 1993, pp. 203-206